2023
DOI: 10.1016/j.bspc.2023.104788
|View full text |Cite
|
Sign up to set email alerts
|

Genetic algorithm-based optimization framework for control parameters of ventricular assist devices

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
4
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 36 publications
1
4
0
Order By: Relevance
“…However, in this case, the MOPC-EIS shows an advantage in accuracy with two fewer points outside the 5% error range and smaller error values, while the MOPC-PC shows a slight tendency to overestimate the flow. The percentage error of the flow estimator was 3.33 ± 0.92%, in agreement with Leao et al [28] and other estimators [30][31][32][33][34][35][36][37][38][39][40][41][42]. The percentage error of the differential pressure estimator was 1.93 ± 0.7%, in agreement with Leao et al [28] and other estimators.…”
Section: Discussionsupporting
confidence: 88%
See 2 more Smart Citations
“…However, in this case, the MOPC-EIS shows an advantage in accuracy with two fewer points outside the 5% error range and smaller error values, while the MOPC-PC shows a slight tendency to overestimate the flow. The percentage error of the flow estimator was 3.33 ± 0.92%, in agreement with Leao et al [28] and other estimators [30][31][32][33][34][35][36][37][38][39][40][41][42]. The percentage error of the differential pressure estimator was 1.93 ± 0.7%, in agreement with Leao et al [28] and other estimators.…”
Section: Discussionsupporting
confidence: 88%
“…However, on the other hand, in vitro testing presents significantly more complex adversities than those that may be encountered in a virtual environment. Therefore, the error obtained in the proposal of this study can be considered satisfactory considering the specialized literature in this field [30][31][32][33][34][35][36][37][38][39][40][41][42]. Nevertheless, in vivo testing also presents even higher levels of complexity that cannot be replicated in an in vitro study, and new studies under these conditions will always be necessary.…”
Section: Discussionmentioning
confidence: 69%
See 1 more Smart Citation
“…Previous studies have shown the effect of intra- and inter-patient variability on the performance of physiologic LVAD controllers by manipulating specific parameters of the CVS in use. 6,16 However, both studies lack the evidence that the “artificial patients” produced by combining different CVS’ parameters are validated against patient or animal data. Additionally, in both studies, the performance of the examined controller was evaluated by using the CVS structure that was used already during development.…”
Section: Discussionmentioning
confidence: 99%
“…Some works consider different patient scenarios by preclinical experiments with a small number of patients 7,8 or by manipulating specific model parameters in vitro . 6,16 These manipulations, however, may have limited validity in imitating a real CVS.…”
mentioning
confidence: 99%